Moreover, autoantibodies against the β2 adrenergic receptor (β2 AdR) and M3 muscarinic receptor were detected in ME/CFS patients [17]. This evidence concerns the gene CHRM3 and myalgic encephalomeyelitis/chronic fatigue syndrome.